All Stories

  1. Methodological guidelines for P2X receptor assays and data interpretation
  2. P2X receptors in immune cells: key regulators of inflammation and immune function
  3. Synthesis and characterization of new P2X7 receptor antagonists as antitumor agents
  4. A Holistic Approach to Identifying a Positron Emission Tomography (PET) Tracer Candidate for In Vivo Imaging of Purinergic P2X7 Receptor in Neuroinflammation
  5. Latest advances on the role of P2X Receptors in colorectal inflammation and cancer
  6. In tribute to Francesco Di Virgilio, a great scientist and a wonderful friend
  7. A step-by-step protocol based on data mining to explore purinergic signaling in glioblastoma
  8. Retinoic acid-induced alterations enhance eATP-mediated anti-cancer effects in glioma cells: Implications for P2X7 receptor variants as key players
  9. In-vivo measurement of the extracellular ATP concentration by bio-luminescence: The pmeLUC probe
  10. P2X7 a new therapeutic target to block vesicle-dependent metastasis in colon carcinoma: role of the A2A/CD39/CD73 axis
  11. P2X7 receptor in macrophage polarization and its implications in neuroblastoma tumor behavior
  12. P2X7 Variants in Pathophysiology
  13. The purinergic receptor P2X7 as a modulator of viral vector-mediated antigen cross-presentation
  14. Preclinical and clinical aspects of P2X receptors as a common route in different diseases: A meeting report
  15. The P2X7 Receptor is a Master Regulator of Microparticle and Mitochondria Exchange in Mouse Microglia
  16. Editorial: Therapy resistance in tumor microenvironment: metabolic reprogramming and purinergic signaling
  17. Bitter Taste Receptor Agonist Denatonium Inhibits Stemness Characteristics in Hematopoietic Stem/Progenitor Cells
  18. The P2X7 Receptor in Oncogenesis and Metastatic Dissemination: New Insights on Vesicular Release and Adenosinergic Crosstalk
  19. EU COST Action CA21130 PRESTO ‘P2X receptors as therapeutic targets’ inaugural meeting report
  20. P2X7-dependent exchange of extracellular microparticles and mitochondria by mouse microglia
  21. Emerging roles of purinergic signaling in anti-cancer therapy resistance
  22. P2X7 receptor isoform B is a key drug resistance mediator for neuroblastoma
  23. A2A Receptor Contributes to Tumor Progression in P2X7 Null Mice
  24. A2A Receptor contributes to tumor progression in P2X7 null mice
  25. Irradiation causes senescence, ATP release, and P2X7 receptor isoform switch in glioblastoma
  26. Administration of P2X7 Receptor Blockers in Oncological Experimental Models
  27. Extracellular ATP is increased by release of ATP-loaded microparticles triggered by nutrient deprivation
  28. The P2RX7B splice variant modulates osteosarcoma cell behaviour and metastatic properties
  29. P2X7 promotes metastatic spreading and triggers release of miRNA-containing exosomes and microvesicles from melanoma cells
  30. Cancer Metabostemness and Metabolic Reprogramming via P2X7 Receptor
  31. Astrocytes‐derived extracellular vesicles in motion at the neuron surface: Involvement of the prion protein
  32. Editorial: Ion Channel Signalling in Cancer: From Molecular Mechanisms to Therapeutics
  33. The ATP/P2X7 axis is a crucial regulator of leukemic initiating cells proliferation and homing and an emerging therapeutic target in acute myeloid leukemia
  34. The P2RX7B splice variant modulates osteosarcoma cell behaviour and metastatic properties
  35. Corrigendum: Denatonium as a Bitter Taste Receptor Agonist Modifies Transcriptomic Profile and Functions of Acute Myeloid Leukemia Cells
  36. Role of ATP in Extracellular Vesicle Biogenesis and Dynamics
  37. P2X7 Receptor in Hematological Malignancies
  38. P2X7 Variants in Oncogenesis
  39. Differential sensitivity of acute myeloid leukemia cells to daunorubicin depends on P2X7A versus P2X7B receptor expression
  40. Denatonium as a Bitter Taste Receptor Agonist Modifies Transcriptomic Profile and Functions of Acute Myeloid Leukemia Cells
  41. Editorial: Emerging Mechanisms in Purinergic Signaling: From Cell Biology to Therapeutic Perspectives
  42. P2X7 in Cancer: From Molecular Mechanisms to Therapeutics
  43. The P2X7 Receptor 489C>T Gain of Function Polymorphism Favors HHV-6A Infection and Associates With Female Idiopathic Infertility
  44. Detection of Extracellular ATP in the Tumor Microenvironment, Using the pmeLUC Biosensor
  45. Role of the P2X7 receptor in tumor-associated inflammation
  46. Amyloid β-dependent mitochondrial toxicity in mouse microglia requires P2X7 receptor expression and is prevented by nimodipine
  47. Involvement of P2X7 Receptors in the Osteogenic Differentiation of Mesenchymal Stromal/Stem Cells Derived from Human Subcutaneous Adipose Tissue
  48. The P2X7 receptor modulates immune cells infiltration, ectonucleotidases expression and extracellular ATP levels in the tumor microenvironment
  49. Structure, function and techniques of investigation of the P2X7 receptor (P2X7R) in mammalian cells
  50. Extracellular ATP and P2 purinergic signalling in the tumour microenvironment
  51. Emerging Roles of Purinergic Signaling in Diabetes
  52. Kinin and Purine Signaling Contributes to Neuroblastoma Metastasis
  53. The P2X7 receptor: A main player in inflammation
  54. ATP Release from Chemotherapy-Treated Dying Leukemia Cells Elicits an Immune Suppressive Effect by Increasing Regulatory T Cells and Tolerogenic Dendritic Cells
  55. P2X7 receptor orchestrates multiple signalling pathways triggering inflammation, autophagy and metabolic/trophic responses.
  56. Extracellular ATP induces apoptosis through P2X7R activation in acute myeloid leukemia cells but not in normal hematopoietic stem cells
  57. P2 receptors in cancer progression and metastatic spreading
  58. Extracellular purines, purinergic receptors and tumor growth
  59. new insights on the therapeutic potential of P2X7 antagonists in human pathology
  60. Emerging Roles of P2X Receptors in Cancer
  61. Editorial (Thematic Issue: Purinergic P2X Receptors: Physiological and Pathological Roles and Potential as Therapeutic Targets)
  62. The P2X7 receptor is a key modulator of the PI3K/GSK3β/VEGF signaling network: evidence in experimental neuroblastoma
  63. Accelerated Tumor Progression in Mice Lacking the ATP Receptor P2X7
  64. Trophic Activity of Human P2X7 Receptor Isoforms A and B in Osteosarcoma
  65. P2X receptors: New players in cancer pain
  66. New intriguing roles of ATP and its receptors in promoting tumor metastasis
  67. Purinergic Signaling in Bone
  68. The P2X7 receptor is a key modulator of aerobic glycolysis
  69. First in vivo demonstration that P2X7 receptor is an oncogene
  70. role of P2X7 receptor in bone cancer and bone metastasis
  71. Purinergic signaling in giant cell formation
  72. The dominant-negative von Willebrand factor gene deletion p.P1127_C1948delinsR: molecular mechanism and modulation
  73. Trophic activity of a naturally occurring truncated isoform of the P2X7 receptor
  74. cAMP efflux from human trophoblast cell lines: a role for multidrug resistance protein (MRP)1 transporter
  75. P2X7: a growth-promoting receptor—implications for cancer
  76. Expression of the P2X7 Receptor Increases the Ca2+ Content of the Endoplasmic Reticulum, Activates NFATc1, and Protects from Apoptosis
  77. Somatostatin as a Regulator of First-Trimester Human Trophoblast Functions
  78. The P2X7 receptor: a key player in IL-1 processing and release
  79. Stimulation of Purinergic Receptors Modulates Chemokine Expression in Human Keratinocytes
  80. Stimulation of P2 (P2X7) receptors in human dendritic cells induces the release of tissue factor-bearing microparticles
  81. The extracellular nucleotide UTP is a potent inducer of hematopoietic stem cell migration
  82. Stimulation of P2 receptors causes release of IL-1β–loaded microvesicles from human dendritic cells
  83. Involvement of the Purinergic P2X7 Receptor in the Formation of Multinucleated Giant Cells
  84. The P2X7 Receptor: A Key Player in IL-1 Processing and Release
  85. P2X7 receptor: Death or life?
  86. Pseudoapoptosis Induced by Brief Activation of ATP-gated P2X7 Receptors
  87. Basal Activation of the P2X7 ATP Receptor Elevates Mitochondrial Calcium and Potential, Increases Cellular ATP Levels, and Promotes Serum-independent Growth
  88. The Antibiotic Polymyxin B Modulates P2X7 Receptor Function
  89. Enhanced P2X7 Activity in Human Fibroblasts From Diabetic Patients: A Possible Pathogenetic Mechanism for Vascular Damage in Diabetes
  90. Tyrosine Phosphorylation of HSP90 within the P2X7 Receptor Complex Negatively Regulates P2X7 Receptors
  91. P2X7 receptor expression in evolutive and indolent forms of chronic B lymphocytic leukemia
  92. Human Leukocyte Antigen-A,-B,-C and -DR Alleles and Soluble Human Leukocyte Antigen Class I Serum Level in Ménière's Disease
  93. Increased Proliferation Rate of Lymphoid Cells Transfected with the P2X7 ATP Receptor
  94. Homology modeling and active-site residues probing of the thermophilicAlicyclobacillus acidocaldariusesterase 2
  95. Overexpression and properties of a new thermophilic and thermostable esterase from Bacillus acidocaldarius with sequence similarity to hormone-sensitive lipase subfamily